| Kla Corporation | 178K | US$53.8M | 25.2% |
| Bristol-myers Squibb Company | 297K | US$17.1M | 8.0% |
| Lam Research Corporation | 35,000 | US$15.2M | 7.1% |
| Intellia Therapeutics, Inc. | 386K | US$6.78M | 3.2% |
| Solid Biosciences Inc. | 666K | US$6.66M | 3.1% |
| Stoke Therapeutics, Inc. | 178K | US$5.83M | 2.7% |
| Ovintiv Inc. (de) | 108K | US$5.66M | 2.6% |
| Nektar Therapeutics | 81,000 | US$5.65M | 2.6% |
| Corcept Therapeutics Incorporated | 57,200 | US$4.97M | 2.3% |
| Neurocrine Biosciences, Inc. | 27,190 | US$4.58M | 2.1% |
| Acadia Pharmaceuticals Inc. | 171K | US$4.33M | 2.0% |
| Protagonist Therapeutics, Inc. | 35,018 | US$4.29M | 2.0% |
| Compass Therapeutics, Inc. | 1.68M | US$3.67M | 1.7% |
| Relmada Therapeutics, Inc. | 408K | US$2.82M | 1.3% |
| Halozyme Therapeutics, Inc. | 33,251 | US$2.6M | 1.2% |
| Celldex Therapeutics, Inc. | 69,900 | US$2.6M | 1.2% |
| Cytokinetics, Incorporated | 30,000 | US$2.56M | 1.2% |
| Olema Pharmaceuticals, Inc. | 199K | US$2.49M | 1.2% |
| Vera Therapeutics, Inc. | 57,758 | US$2.48M | 1.2% |
| United Therapeutics Corporation | 4,506 | US$2.44M | 1.1% |
| Zenas Biopharma, Inc. | 93,601 | US$2.38M | 1.1% |
| Pacific Biosciences Of California, Inc. | 1.35M | US$2.27M | 1.1% |
| Abivax Sa | 17,000 | US$2.27M | 1.1% |
| Vir Biotechnology, Inc. | 220K | US$2.24M | 1.0% |
| Biogen Inc. | 9,000 | US$1.94M | 0.91% |
| Eqt Corporation | 34,619 | US$1.84M | 0.86% |
| Bioage Labs, Inc. | 69,000 | US$1.69M | 0.79% |
| Travere Therapeutics, Inc. | 29,000 | US$1.65M | 0.77% |
| Axsome Therapeutics, Inc. | 6,000 | US$1.47M | 0.69% |
| Foghorn Therapeutics Inc. | 282K | US$1.38M | 0.64% |
| Xenon Pharmaceuticals Inc. | 21,032 | US$1.27M | 0.59% |
| Novo Nordisk A/s Class B | 24,000 | US$1.15M | 0.54% |
| Freeport-mcmoran, Inc. | 18,035 | US$1.13M | 0.53% |
| Immunome, Inc. | 50,000 | US$1.06M | 0.50% |
| Harrow, Inc. | 24,000 | US$1.02M | 0.48% |
| Definium Therapeutics, Inc. | 20,000 | US$941K | 0.44% |
| Bridgebio Pharma, Inc. | 8,741 | US$651K | 0.30% |
| 4d Molecular Therapeutics, Inc. | 48,505 | US$645K | 0.30% |
| Phathom Pharmaceuticals, Inc. | 55,000 | US$597K | 0.28% |
| Camp4 Therapeutics Corporation | 120K | US$524K | 0.25% |
| Savara, Inc. | 80,000 | US$493K | 0.23% |
| Candel Therapeutics, Inc. | 47,756 | US$492K | 0.23% |
| Altimmune, Inc. | 153K | US$464K | 0.22% |
| Cullinan Therapeutics, Inc. | 20,000 | US$364K | 0.17% |
| Trinity Capital Inc. | 20,000 | US$358K | 0.17% |
| Capricor Therapeutics, Inc. | 14,352 | US$346K | 0.16% |
| Castle Biosciences, Inc. | 12,984 | US$310K | 0.14% |
| Invivyd, Inc. | 342K | US$299K | 0.14% |
| Grace Therapeutics, Inc. | 120K | US$272K | 0.13% |
| Kayne Anderson Bdc, Inc. | 20,000 | US$271K | 0.13% |
| Voyager Therapeutics, Inc. | 75,147 | US$263K | 0.12% |
| Pulmonx Corporation | 201K | US$261K | 0.12% |
| Ocular Therapeutix, Inc. | 20,655 | US$203K | 0.09% |
| Kyntra Bio, Inc. | 22,566 | US$170K | 0.08% |
| Elutia, Inc. | 165K | US$162K | 0.08% |
| Lipocine Inc. | 16,712 | US$42,783 | 0.02% |
| Docgo Inc. | 39,062 | US$20,160 | <0.01% |
| Gossamer Bio, Inc. | 18,176 | US$2,992 | <0.01% |
| Kalvista Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Phreesia, Inc. | 0 | US$0 | 0.00% |
| Regenxbio Inc. | 0 | US$0 | 0.00% |
| Rocket Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Ultragenyx Pharmaceutical Inc. | 0 | US$0 | 0.00% |
| Verastem, Inc. | 0 | US$0 | 0.00% |
| Viridian Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Zentalis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Apellis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Arcus Biosciences, Inc. | 0 | US$0 | 0.00% |
| Engene Holdings Inc. | 0 | US$0 | 0.00% |
| Ideaya Biosciences, Inc. | 0 | US$0 | 0.00% |